Title:
TRISULFIDE COMPOUND AND CLATHRATE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/045212
Kind Code:
A1
Abstract:
A compound represented by formula (1) or (3). [Compound 1] [In the formula, R1 and R2 each independently are a hydrogen atom; a C1-6 alkyl group having one or more substituents selected from the group consisting of a carboxy group and -OR5; a C2-6 alkyl group having one or more substituents selected from the group consisting of -NR6R7 and -N+R9R10R11; or –(CH2CH2O)nR8, R5, R6, R7, R8, R9, R10, and R11 each independently are a hydrogen atom or a C1-3 alkyl group, and n is an integer of 2-5.] [Compound 2] [In the formula, R4 represents a C1-6 alkyl group having one or more substituents selected from the group consisting of a carboxy group and -OR5; a C2-6 alkyl group having one or more substituents selected from the group consisting of -NR6R7 and -N+R9R10R11; or –(CH2CH2O)nR8, and R5-R11 and n are the same as above.]
Inventors:
TOMONAGA SHOICHIRO (JP)
ISOBE TAKAHIRO (JP)
OHSHIMA ETSUO (JP)
ISOBE TAKAHIRO (JP)
OHSHIMA ETSUO (JP)
Application Number:
PCT/JP2021/031222
Publication Date:
March 03, 2022
Filing Date:
August 25, 2021
Export Citation:
Assignee:
KYOWA PHARMA CHEMICAL CO LTD (JP)
International Classes:
C07D341/00; A61K31/385; A61K47/69; A61P29/00; C08B37/16
Foreign References:
| CN111320603A | 2020-06-23 | |||
| CN107652264A | 2018-02-02 | |||
| CN101607955A | 2009-12-23 | |||
| JPS377970B1 | 1962-07-11 | |||
| JPH07188304A | 1995-07-25 | |||
| JP2005530866A | 2005-10-13 | |||
| JP2019534864A | 2019-12-05 | |||
| CN107652264A | 2018-02-02 |
Attorney, Agent or Firm:
HASEGAWA Yoshiki et al. (JP)
Download PDF: